Landmark study tracks cancer risk in rare genetic blood disorders
NCT ID NCT00027274
Summary
This study aims to understand why people with inherited bone marrow failure syndromes have a higher risk of developing cancer. Researchers will follow 4,000 participants, including patients with these rare genetic conditions and their family members, to track cancer rates and identify risk factors. The goal is to gather knowledge that could lead to better cancer screening and prevention strategies for these high-risk families.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FANCONI ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Institute - Shady Grove
RECRUITINGRockville, Maryland, 20850, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.